Exai Bio Secures $67.5 Million Series A Financing to Advance Next-Generation, RNA-Based Liquid Biopsy Platform for Early Cancer Detection
Israel-based seed invstor Lool Ventures has hit a $60m first close for its third fundraise, putting it well on the way to its goal. The post Israel’s Lool Ventures races towards Fund III goal through
Recent Comments